A low haemoglobin count, older age and high BMI are possible risk factors for developing nerve damage after cancer treatment, a UNSW-led study has found.
Teachers from UNSW Business School, Engineering and Medicine & Health have been awarded citations for outstanding contributions to student learning at the 2020 Australian Awards for University Teaching.
A new systematic review led by UNSW Sydney has found that treating low back pain with antidepressant medicines provides no important benefits and has the potential to cause harm.
Our new research found gaps in COVID information available to culturally and linguistically diverse communities. But there are ways we can improve — because community ownership is crucial.
UNSW Sydney and the Garvan Institute of Medical Research researchers will lead the program, thanks to a $3.75 million grant from the Cancer Institute NSW.
The strategy of covering the mouth and nose to avoid being infected with coronavirus and other airborne diseases may neglect the largest and weakest point of entry to the human body – the eyes – specialists from UNSW Sydney and ANU suggest.
A rise in vaccine-resistant bacteria shows the need for a new vaccine to fight childhood empyema after a spike in hospitalisations, a new UNSW study reveals.
People with non-alcohol-related liver cancer have a unique gut microbiome profile which could help predict disease risk, a UNSW Sydney study has found.
This World Cancer Day, a range of UNSW Medicine & Health cancer researchers, clinicians and scientists are available for media interviews across all aspects of cancer, from prevention and detection to treatment and survivorship.
